Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 175 of the 175 references it cites were found in a registry or an index.

Obesity, estrogens and adipose tissue dysfunction - implications for pulmonary arterial hypertension

Open access
Mair, Kirsty M., Gaw, Rosemary, MacLean, Margaret R. · 2020 · Pulmonary Circulation

Abstract

Obesity is a prevalent global public health issue characterized by excess body fat. Adipose tissue is now recognized as an important endocrine organ releasing an abundance of bioactive adipokines including, but not limited to, leptin, adiponectin and resistin. Obesity is a common comorbidity amongst pulmonary arterial hypertension patients, with 30% to 40% reported as obese, independent of other comorbidities associated with pulmonary arterial hypertension (e.g. obstructive sleep apnoea). An ‘obesity paradox’ has been observed, where obesity has been associated with subclinical right ventricular dysfunction but paradoxically may confer a protective effect on right ventricular function once pulmonary hypertension develops. Obesity and pulmonary arterial hypertension share multiple pathophysiological mechanisms including inflammation, oxidative stress, elevated leptin (proinflammatory) and reduced adiponectin (anti‐inflammatory). The female prevalence of pulmonary arterial hypertension has instigated the hypothesis that estrogens may play a causative role in its development. Adipose tissue, a major site for storage and metabolism of sex steroids, is the primary source of estrogens and circulating estrogens levels which are elevated in postmenopausal women and men with pulmonary arterial hypertension. This review discusses the functions of adipose tissue in both health and obesity and the links between obesity and pulmonary arterial hypertension. Shared pathophysiological mechanisms and the contribution of specific fat depots, metabolic and sex‐dependent differences are discussed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/2045894020952023

Cites

175 of 175 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1. Adipose tissue dysfunction in obesity. Insufficient storage capacity of adipocytes in obesity results in systemic inflammation, increased lipolysis, hypoxia and altered adipokine secretion. These factors result in the development of insulin resistance and metabolic syndrome which further impairs adipose tissue function and contributes to obesity-related diseases. CRP: C-reactive protein; ECM: extracellular matrix; FFAs: free fatty acids; HIF1α: hypoxia-inducible factor-1; IL-6: interleukin-6; TNFα: tumour necrosis factor-α.
Fig. 1. Adipose tissue dysfunction in obesity. Insufficient storage capacity of adipocytes in obesity results in systemic inflammation, increased lipolysis, hypoxia and altered adipokine secretion. These factors result in the development of insulin resistance and metabolic syndrome which further impairs adipose tissue function and contributes to obesity-related diseases. CRP: C-reactive protein; ECM: extracellular matrix; FFAs: free fatty acids; HIF1α: hypoxia-inducible factor-1; IL-6: interleukin-6; TNFα: tumour necrosis factor-α.CC BY · PubMed Central
Fig. 2. Local production of estrogens in human adipose tissue from circulating precursors. DHEA: dehydroepiandrosterone; DHEA-S: DHEA sulfate; 17β-HSD: 17β-hydroxysteroid dehydrogenase; 3β-HSD: 3β-hydroxysteroid dehydrogenase.
Fig. 2. Local production of estrogens in human adipose tissue from circulating precursors. DHEA: dehydroepiandrosterone; DHEA-S: DHEA sulfate; 17β-HSD: 17β-hydroxysteroid dehydrogenase; 3β-HSD: 3β-hydroxysteroid dehydrogenase.CC BY · PubMed Central
Fig. 3. Mechanisms mediating the upregulation of aromatase and estrogen (E2) production in adipose tissue. Increased local inflammation due to macrophage infiltration in obese adipose tissue results in the production of inflammatory mediators known to induce the transcriptional upregulation of aromatase resulting in increased E2 production. COX2: cyclooxygenase-2; E2: estrogen; IL-6: interleukin-6; PGE2: prostaglandin E2; TNFα: tumour necrosis factor-α.
Fig. 3. Mechanisms mediating the upregulation of aromatase and estrogen (E2) production in adipose tissue. Increased local inflammation due to macrophage infiltration in obese adipose tissue results in the production of inflammatory mediators known to induce the transcriptional upregulation of aromatase resulting in increased E2 production. COX2: cyclooxygenase-2; E2: estrogen; IL-6: interleukin-6; PGE2: prostaglandin E2; TNFα: tumour necrosis factor-α.CC BY · PubMed Central
Fig. 4. Estrogen metabolism. Estrone (E1) and estradiol (E2) are synthesized by aromatase. Hydroxylation of E1 and E2 occurs at C2, C4 and C16 positions by cytochrome P450 enzymes (the most prominent being CYP1A2 and CYP1B1 promoting beneficial and detrimental hydroxylation, respectively) resulting in the formation of 16α-hydroxyestrogens, 2-hydroxyestogens and 4-hydroxyestrogens by cytochrome P450 enzymes. The 2- and 4- hydroxyestrogens are converted to 2- and 4-methoxyestrogens via COMT. All E1 and E2 metabolites are maintained in equilibrium by 17β-HSD1 and 17β-HSD2 enzymes. PAH: pulmonary arterial hypertension; COMT: catechol-O-methyltransferase; 17β-HSD: 17β-hydroxysteroid dehydrogenase; 16OHE1: 16α-hydroxyestrone; 16OHE2: 16α-hydroxyestradiol; 2OHE1: 2-hydroxyestrone; 2OHE2: 2-hydroxyestradiol; 4OHE1: 4-hydroxyestrone; 4OHE2: 4-hydroxyestradiol; 2MeOE1: 2-methoxyestrone; 2MeOE2: 2-methoxyestradiol; 4MeOE1: 4-methoxyestrone; 4MeOE2: 4-methoxyestradiol.
Fig. 4. Estrogen metabolism. Estrone (E1) and estradiol (E2) are synthesized by aromatase. Hydroxylation of E1 and E2 occurs at C2, C4 and C16 positions by cytochrome P450 enzymes (the most prominent being CYP1A2 and CYP1B1 promoting beneficial and detrimental hydroxylation, respectively) resulting in the formation of 16α-hydroxyestrogens, 2-hydroxyestogens and 4-hydroxyestrogens by cytochrome P450 enzymes. The 2- and 4- hydroxyestrogens are converted to 2- and 4-methoxyestrogens via COMT. All E1 and E2 metabolites are maintained in equilibrium by 17β-HSD1 and 17β-HSD2 enzymes. PAH: pulmonary arterial hypertension; COMT: catechol-O-methyltransferase; 17β-HSD: 17β-hydroxysteroid dehydrogenase; 16OHE1: 16α-hydroxyestrone; 16OHE2: 16α-hydroxyestradiol; 2OHE1: 2-hydroxyestrone; 2OHE2: 2-hydroxyestradiol; 4OHE1: 4-hydroxyestrone; 4OHE2: 4-hydroxyestradiol; 2MeOE1: 2-methoxyestrone; 2MeOE2: 2-methoxyestradiol; 4MeOE1: 4-methoxyestrone; 4MeOE2: 4-methoxyestradiol.CC BY · PubMed Central
Fig. 5. Changes in estrogen metabolism in adipose tissue and its contribution to the development of obesity-related PAH. Obesity causes an increase in the expression of aromatase and CYP1B1 in adipose tissue resulting in the increased production of estrogen (E2) and its metabolite 16OHE1. In particular, 16OHE1 induces proliferation of PASMCs and contributes to pulmonary vascular remodelling in PAH. CYP1B1 is also associated with insulin resistance, another underlying pathology linked with PAH. PAH: pulmonary arterial hypertension; 16OHE1: 16α-hydroxyestrone; PASMCs: pulmonary artery smooth muscle cells.
Fig. 5. Changes in estrogen metabolism in adipose tissue and its contribution to the development of obesity-related PAH. Obesity causes an increase in the expression of aromatase and CYP1B1 in adipose tissue resulting in the increased production of estrogen (E2) and its metabolite 16OHE1. In particular, 16OHE1 induces proliferation of PASMCs and contributes to pulmonary vascular remodelling in PAH. CYP1B1 is also associated with insulin resistance, another underlying pathology linked with PAH. PAH: pulmonary arterial hypertension; 16OHE1: 16α-hydroxyestrone; PASMCs: pulmonary artery smooth muscle cells.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 175 references

Research works printed but not linked: 3

  1. 10.1164/rccm.201509-1785OC · DOI
  2. 10.1183/13993003.00467-2018 · DOI
  3. Nadler L, 2008, Anti‐CYP1B1 biologic and clinical responses are induced in patients with advanced stage solid tumors with cyclophosphamide pre‐dosing and immunization with ZYC300, Cancer Res, 68, 2544

Cited by

See all 129

Metadata

Authors
Mair, K. M., Gaw, R., & MacLean, M. R.
Affiliations
University of Strathclyde (GB)
Corresponding author
MacLean, Margaret R.
Venue
Pulmonary Circulation
Publisher
Wiley
Published
2020-07
Volume
10
Issue
3
Pages
1-21
ISSN
  • 2045-8932 (ISSN-L)
  • 2045-8940
OpenAlex
W3087589929
Cited by
129
References
175
Citations by year
2026: 11 · 2025: 36 · 2024: 35 · 2023: 25 · 2022: 17 · 2021: 5
FWCI
1.65
Type
journal article
Language
en
Open access
Locations
  • Pulmonary Circulation (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Strathprints: The University of Strathclyde institutional repository (University of Strathclyde) (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
British Heart Foundation (RG/16/2/32153, PG/15/63/31659)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Keywords
obesity, pulmonary arterial hypertension, estrogen, adipose tissue dysfunction, adipokines, leptin, adiponectin, resistin, obesity paradox, right ventricular function, inflammation, oxidative stress, sex differences, postmenopausal women, fat depots, sex steroids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Obesity, estrogens and adipose tissue dysfunction - implications for pulmonary arterial hypertension. https://app.cochat.ai/papers/10.1177/2045894020952023
The paper
Mair, K. M., Gaw, R., & MacLean, M. R. (2020). Obesity, estrogens and adipose tissue dysfunction - implications for pulmonary arterial hypertension. Pulmonary Circulation. https://doi.org/10.1177/2045894020952023

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.